Form 4 for IKT Inhibikase Therapeutics, Inc.
Accepted 2026-07-31 16:05:14 ET · period of report 2026-07-30 · accession 0001193125-26-328467 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-07-31 16:05 | 2026-07-30 | IKT | BERMAN DENNIS N | Dir | M - OptEx | $1.26 | +21.9K | 21.9K | New | +$27.5K |
| D | 2026-07-31 16:05 | 2026-07-30 | IKT | BERMAN DENNIS N | Dir | M - OptEx | $0.00 | -21.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-30 | M | A | 21,854 | $1.26 | 21,854 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-07-30 | M | D | 21,854 | $0.00 | 0 | D | $1.26 · — to 2026-08-31 | 21,854 Common Stock | (F1) The options are fully vested and exercisable. |